Showing results (441-450 of 500) with videos related to
Sort By:
Pageof 50
Cell Discovery|September 8, 2022
A novel cyclic γ-AApeptide-based long-acting pan-coronavirus fusion inhibitor with potential oral bioavailability by targeting two sites in spike proteinSongyi Xue, Xinling Wang, Lei Wang, et al.Journal of Virology|May 3, 2014
Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodiesTianlei Ying, Lanying Du, Tina W Ju, et al.Nature Communications|January 30, 2014
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitorLu Lu, Qi Liu, Yun Zhu, et al.Cell|January 31, 2025
Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral targetLixiao Xing, Zhimin Liu, Xinling Wang, et al.Cell Reports|July 21, 2021
A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variantBali Zhao, Jingyi Yang, Bing He, et al.Cell|April 24, 2007
Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptideJan Münch, Ludger Ständker, Knut Adermann, et al.Human Vaccines & Immunotherapeutics|December 21, 2013
Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidateWen-Hsiang Chen, Lanying Du, Shivali M Chag, et al.Journal of Virology|June 29, 2018
A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoVGuangyu Zhao, Lei He, Shihui Sun, et al.Vaccine|March 3, 2018
Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigenMun Peak Nyon, Lanying Du, Chien-Te Kent Tseng, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Recombinant Ov-ASP-1, a Th1-biased protein adjuvant derived from the helminth Onchocerca volvulus, can directly bind and activate antigen-presenting cellsYuxian He, Sophie J Barker, Angus J MacDonald, et al.Pageof 50